The Indian pharmaceutical landscape is increasingly characterized by a concentration of power among a handful of prominent players. While the sector boasts a vast number of companies, a few giants – including Sun, Cadila Healthcare, and Divi's – consistently hold a significant portion of the turnover and power within various therapeutic fields.